|
C2ORF67 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.15530002126252E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58335999999037E-05 |
| Normal-vs-Stage2 |
1.093960E-02 |
| Normal-vs-Stage3 |
9.308200E-02 |
| Normal-vs-Stage4 |
1.996620E-01 |
| Stage1-vs-Stage2 |
3.250800E-01 |
| Stage1-vs-Stage3 |
2.987600E-01 |
| Stage1-vs-Stage4 |
8.338800E-01 |
| Stage2-vs-Stage3 |
1.128650E-01 |
| Stage2-vs-Stage4 |
7.095600E-01 |
| Stage3-vs-Stage4 |
5.281800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02689999836869E-08 |
| Normal-vs-AfricanAmerican |
7.027300E-04 |
| Normal-vs-Asian |
4.660600E-01 |
| Caucasian-vs-AfricanAmerican |
6.463000E-01 |
| Caucasian-vs-Asian |
4.106600E-01 |
| AfricanAmerican-vs-Asian |
4.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.69049996013149E-09 |
| Normal-vs-Female |
4.003800E-04 |
| Male-vs-Female |
4.331600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.954400E-02 |
| Normal-vs-Extreme_Weight |
1.044660E-03 |
| Normal-vs-Obese |
9.69840000000222E-05 |
| Normal-vs-Extreme_Obese |
4.974300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.640600E-01 |
| Normal_Weight-vs-Obese |
2.444400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.851200E-01 |
| Extreme_Weight-vs-Obese |
2.831200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.207400E-01 |
| Obese-vs-Extreme_Obese |
6.903000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.754800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.04310029900046E-10 |
| Normal-vs-Age(61-80Yrs) |
2.040800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.602800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.296400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.950000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.138200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.027540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.118580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.305400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72595271408227E-12 |
| Normal-VS-Type2 PRCC |
1.588430E-01 |
| Normal-VS-KIRP CIMP |
8.826600E-01 |
| Normal-VS-Unclassified PRCC |
2.879400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.52474999999264E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.424500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.718400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.826000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.577600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.969600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.465700E-02 |
| Normal-vs-N1 |
1.105880E-02 |
| Normal-vs-N2 |
8.257600E-01 |
| N0-vs-N1 |
1.269380E-01 |
| N0-vs-N2 |
4.207200E-01 |
| N1-vs-N2 |
2.487800E-01 |
|
|
